InvestSMART

Hydrix Limited (ASX: HYD) - Announcements

- Current share price for HYD : $0.003

ASX company news and announcements for Hydrix Limited (HYD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Hydrix Limited (HYD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Hydrix Limited (HYD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Hydrix Limited (HYD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Update - Proposed issue of securities - HYD 8 Sep 2023 3:25PM $0.027 $0.003 fallen by 88.89%
$4 FY2023 Letter from Executive Chairman 29 Aug 2023 9:27AM $0.032 $0.003 fallen by 90.63%
$4 FY2023 Results Announcement 29 Aug 2023 9:25AM $0.032 $0.003 fallen by 90.63%
$4 FY2023 Appendix 4E and Financial Report 29 Aug 2023 9:17AM $0.032 $0.003 fallen by 90.63%
$4 Update - Proposed issue of securities - HYD 25 Aug 2023 6:14PM $0.032 $0.003 fallen by 90.63%
$4 Update - Proposed issue of securities - HYD 18 Aug 2023 5:05PM $0.033 $0.003 fallen by 90.91%
$4 Investor Presentation 31 Jul 2023 6:24PM $0.027 $0.003 fallen by 88.89%
$4 Quarterly Activities/App 4C & Convertible Note Capital Raise 31 Jul 2023 6:23PM $0.027 $0.003 fallen by 88.89%
$4 Proposed issue of securities - HYD 31 Jul 2023 6:14PM $0.027 $0.003 fallen by 88.89%
$4 Notification of cessation of securities - HYD 17 Jul 2023 12:44PM $0.033 $0.003 fallen by 90.91%
$4 Notification of cessation of securities - HYD 17 Jul 2023 12:43PM $0.033 $0.003 fallen by 90.91%
$4 Notification of cessation of securities - HYD 17 Jul 2023 12:41PM $0.033 $0.003 fallen by 90.91%
$4 Notification of cessation of securities - HYD 17 Jul 2023 12:39PM $0.033 $0.003 fallen by 90.91%
$4 Hydrix Medical appoints Guardian sub-distributor in Malaysia 17 May 2023 1:50PM $0.036 $0.003 fallen by 91.55%
$4 Hydrix signs distribution agreement with Implicity 16 May 2023 9:59AM $0.035 $0.003 fallen by 91.43%
$4 Hydrix Ventures - Avertix Medical NASDAQ Listing Update 16 May 2023 8:52AM $0.035 $0.003 fallen by 91.43%
$4 Hydrix Ventures - AngelMed to merge with NASDAQ Company 4 May 2023 9:46AM $0.039 $0.003 fallen by 92.31%
$4 Hydrix signs agreement to sell EIQ's EchoSolv platform 2 May 2023 9:20AM $0.037 $0.003 fallen by 91.89%
$4 EIQ: Echo IQ Expands Commercial Footprint 2 May 2023 8:16AM $0.037 $0.003 fallen by 91.89%
$4 Quarterly Activities/Appendix 4C Cash Flow Report 20 Apr 2023 9:33AM $0.041 $0.003 fallen by 92.68%
$4 Hydrix client & investee Gyder Surgical obtains TGA approval 19 Apr 2023 9:12AM $0.036 $0.003 fallen by 91.67%
$4 Hydrix signs $1.5m revolving loan facility 18 Apr 2023 10:13AM $0.040 $0.003 fallen by 92.50%
$4 Notification of cessation of securities - HYD 14 Apr 2023 6:25PM $0.042 $0.003 fallen by 92.86%
$4 Notification of cessation of securities - HYD 14 Apr 2023 6:22PM $0.042 $0.003 fallen by 92.86%
$4 Notification of cessation of securities - HYD 14 Apr 2023 6:21PM $0.042 $0.003 fallen by 92.86%

151 - 175 of 497 results

Page 7 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.